Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets.
Angori S, Banaei-Esfahani A, Mühlbauer K, Bolck HA, Kahraman A, Karakulak T, Poyet C, Feodoroff M, Potdar S, Kallioniemi O, Pietiäinen V, Schraml P, Moch H.
Angori S, et al. Among authors: schraml p.
Eur Urol Focus. 2023 Sep;9(5):751-759. doi: 10.1016/j.euf.2023.03.005. Epub 2023 Mar 16.
Eur Urol Focus. 2023.
PMID: 36933996
Free article.